
|

| |
Track the *RXCAN Index |
 |
|
 | Cancer Stocks (*RXCAN) |
| |
Cancer Ideas |
|
|
|
Cancer Performance |
|
|
|
Cancer Community |
|
| |
|
Index Description: These medical firms have significant exposure to cancer detection and treatment
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.5%
+0.4%
+17.1%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.4%
-6.6%
-4.0%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$2.2B
18.1
0.2%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| AEZS |
$2.08 |
+0.02 |
+1.0% |
134,419 |
63% |
$52.6M |
- |
22% |
-63% |
No Alerts/News
|
|
|
| ARIA |
$17.53 |
+0.91 |
+5.5% |
3,400,540 |
116% |
$3.2B |
- |
16% |
-31% |
2 Alerts (0 News) - View
|
|
|
| ARRY |
$5.88 |
+0.22 |
+3.9% |
635,056 |
48% |
$686.1M |
- |
96% |
-10% |
No Alerts/News
|
|
|
| AVEO |
$2.90 |
+0.01 |
+0.3% |
1,256,297 |
37% |
$150.3M |
- |
29% |
-79% |
2 Alerts (0 News) - View
|
|
|
| BCRX |
$1.70 |
-0.01 |
-0.6% |
804,933 |
41% |
$87.3M |
- |
57% |
-66% |
No Alerts/News
|
|
|
| CTIC |
$1.32 |
+0.10 |
+8.2% |
3,016,676 |
469% |
$148.6M |
- |
29% |
-75% |
1 Alert (0 News) - View
|
|
|
| CVM |
$0.26 |
+0.01 |
+2.8% |
809,687 |
77% |
$79.7M |
- |
26% |
-54% |
No Alerts/News
|
|
|
| CYCC |
$3.07 |
+0.03 |
+1.0% |
341,732 |
143% |
$33.2M |
- |
5% |
-62% |
4 Alerts (1 News) - View
|
|
|
| CYTK |
$1.15 |
-0.01 |
-0.9% |
522,426 |
30% |
$168.4M |
- |
102% |
-21% |
No Alerts/News
|
|
|
| DCTH |
$0.44 |
0.00 |
-0.9% |
1,125,626 |
31% |
$39.9M |
- |
17% |
-82% |
1 Alert (0 News) - View
|
|
|
| DNDN |
$3.96 |
+0.02 |
+0.5% |
2,735,325 |
56% |
$624.7M |
- |
7% |
-50% |
No Alerts/News
|
|
|
| ENZN |
$3.14 |
+0.01 |
+0.3% |
86,296 |
20% |
$137.2M |
- |
7% |
-58% |
No Alerts/News
|
|
|
| EXEL |
$4.61 |
+0.12 |
+2.7% |
922,200 |
57% |
$847.2M |
- |
10% |
-34% |
No Alerts/News
|
|
|
| GERN |
$1.12 |
0.00 |
0.0% |
275,068 |
40% |
$146.0M |
- |
23% |
-63% |
No Alerts/News
|
|
|
| GNBT |
$0.03 |
0.00 |
+1.1% |
392,358 |
35% |
$19.4M |
- |
33% |
-76% |
No Alerts/News
|
|
|
| GTXI |
$6.35 |
+0.75 |
+13.4% |
1,076,099 |
317% |
$399.3M |
- |
143% |
8% |
3 Alerts (0 News) - View
|
|
|
| HSP |
$35.92 |
-0.11 |
-0.3% |
904,928 |
66% |
$5.9B |
- |
26% |
-5% |
No Alerts/News
|
|
|
| ISIS |
$20.81 |
+0.35 |
+1.7% |
906,524 |
51% |
$2.1B |
- |
175% |
-10% |
1 Alert (0 News) - View
|
|
|
| KERX |
$8.05 |
+0.11 |
+1.4% |
1,392,027 |
52% |
$657.8M |
- |
419% |
-19% |
1 Alert (0 News) - View
|
|
|
| MEIP |
$8.48 |
-0.06 |
-0.7% |
66,238 |
91% |
$127.5M |
- |
328% |
-36% |
No Alerts/News
|
|
|
| MELA |
$1.09 |
+0.01 |
+1.4% |
405,616 |
81% |
$46.9M |
- |
7% |
-75% |
No Alerts/News
|
|
|
| MSTX |
$0.65 |
-0.01 |
-1.5% |
230,027 |
141% |
$30.0M |
- |
44% |
-29% |
No Alerts/News
|
|
|
| MYGN |
$33.01 |
-0.05 |
-0.1% |
892,815 |
69% |
$2.6B |
- |
50% |
-5% |
No Alerts/News
|
|
|
| ONTY |
$2.00 |
0.00 |
0.0% |
1,333,064 |
117% |
$114.4M |
- |
17% |
-68% |
2 Alerts (0 News) - View
|
|
|
| ONXX |
$92.91 |
-1.43 |
-1.5% |
1,329,967 |
119% |
$6.7B |
- |
125% |
-9% |
1 Alert (0 News) - View
|
|
|
| PDLI |
$8.37 |
+0.16 |
+1.9% |
1,941,739 |
108% |
$1.1B |
7.3% |
35% |
-1% |
1 Alert (0 News) - View
|
|
|
| PGNX |
$4.02 |
-0.15 |
-3.6% |
211,164 |
63% |
$205.1M |
- |
185% |
-63% |
1 Alert (0 News) - View
|
|
|
| PPHM |
$1.66 |
-0.17 |
-9.3% |
5,722,497 |
236% |
$222.0M |
- |
293% |
-70% |
1 Alert (0 News) - View
|
|
|
| QLTI |
$7.93 |
+0.08 |
+1.0% |
56,228 |
81% |
$400.6M |
- |
25% |
-13% |
No Alerts/News
|
|
|
| REGN |
$259.96 |
-3.68 |
-1.4% |
804,876 |
49% |
$25.4B |
- |
142% |
-8% |
2 Alerts (1 News) - View
|
|
|
| SGEN |
$35.73 |
-0.02 |
-0.1% |
450,242 |
55% |
$4.3B |
- |
88% |
-8% |
No Alerts/News
|
|
|
| TELK |
$1.36 |
+0.01 |
+0.4% |
9,182 |
35% |
$6.2M |
- |
25% |
-81% |
No Alerts/News
|
|
|
| UTHR |
$68.47 |
+0.36 |
+0.5% |
801,263 |
101% |
$3.4B |
- |
64% |
-1% |
1 Alert (0 News) - View
|
|
|
| VRTX |
$79.47 |
+2.09 |
+2.7% |
1,722,364 |
50% |
$17.3B |
- |
107% |
-9% |
No Alerts/News
|
|
|
| XOMA |
$4.18 |
+0.02 |
+0.5% |
397,566 |
49% |
$346.4M |
- |
88% |
-5% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering CYCC CYCCP
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 21, 04:13PM from (globenewswire.com) BERKELEY HEIGHTS, N.J., May 21, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel
Flag
Post a comment
Dupilumab, a New Drug, May Help Some Asthmatics REGN SNY
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 21, 04:12PM from (www.nytimes.com) The number of asthma attacks or other outbreaks of symptoms decreased by 87 percent in those getting the drug, Dupilumab,
Flag
Post a comment
$307,000-a-year Vertex Drug: Billions in Sales? VRTX
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 20, 12:50PM from (ycharts.com) Here is a question that is likely to plague the pharmaceutical industry and patient advocacy groups for some time to come:
Flag
Post a comment
UK to Pilot Illumina Genetic Test for Breast, Ovarian Cancer MYGN ILMN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 20, 10:07AM from (www.bloomberg.com) The U.K. is piloting a new genetic test developed by Illumina Inc. (ILMN) to help cancer patients and their doctors better
Flag
Post a comment
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index PGNX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 17, 05:43PM from (globenewswire.com) TARRYTOWN, N.Y., May 17, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has
Flag
Post a comment
Mid-Morning Market Update: Housing Starts Plummet, Initial Jobless Claims Rise AMD CSCO HALO DRYS ONTY
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 16, 10:51AM from (www.benzinga.com) Following the market opening Wednesday, the Dow traded down 0.12 percent to 15,257.00, while the NASDAQ rose 0.15 percent
Flag
Post a comment
Top New Biotech Ideas from PropThink CELG REGN CBST VPHM ONXX AVEO MAKO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com) The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)
Flag
Post a comment
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials ARRY
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 02:18AM from (www.bloomberg.com) AstraZeneca Plc (AZN) will move three experimental cancer treatments into late-stage development as generic competition for its best-selling drugs intensifies.
Flag
Post a comment
Company That Sells Angelina Jolie’s Blood Test MYGN MON
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 15, 03:18PM from (ycharts.com) Shares of Myriad Genetics (MYGN) spiked higher yesterday to hit their highest levels on record since mid-2009, as seen in
Flag
Post a comment
What We're Reading ~ Analytical Links 5/15/13 VZ VOD DLTR HSP FLT
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com) Meb Faber's new book: Shareholder Yield [Meb Faber]
Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
Flag
Post a comment
Dendreon Gets Prostate Cancer Competition for Provenge from Bayer’s Xofigo DNDN
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 11:15AM from (247wallst.com) Dendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer
Flag
Post a comment
Deutsche Bank Firm on Biotech Stocks to Buy AMGN CELG REGN BIIB VRTX GILD ALXN ONXX DB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com) Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and
Flag
Post a comment
Roche Wins FDA Approval for Test to Target Lung Cancer MYGN QGEN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 05:43PM from (www.bloomberg.com) Roche Holding AG (ROG), the world’s biggest maker of cancer drugs, won U.S. approval to sell a gene mutation test that
Flag
Post a comment
Myriad Genetics, Angelina Jolie, and Genomics in Focus MYGN GHDX ROSG
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 14, 01:58PM from (247wallst.com) Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic
Flag
Post a comment
Myriad Genetics to Present at the Bank of America Merrill Lynch Health Care Conference MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 07:13AM from (globenewswire.com) SALT LAKE CITY, May 14, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum,
Flag
Post a comment
|
|
|